Werkgelegenheid, sociale zaken en inclusie

26/03/2021
Study on hazardous medicinal products

Study on hazardous medicinal products

The aim of this study is to investigate options for protecting workers from exposure to hazardous medicinal products (HMPs), including cytotoxic medicinal products, that fall within the scope of the CMD (the Carcinogens and Mutagens Directive (2004/37 EC)).

Catalog N. : KE-04-21-039-EN-N

Verkrijgbaar bij  EU Publications

Delen